Papers
4
Total Citations
84
H-Index
4
About
Dr. Bart Geboers is a pioneering urologic surgeon and researcher whose work sits at the intersection of precision oncology and advanced surgical robotics. His primary research focuses on prostate cancer, with key contributions in three areas: PSMA-radioguided surgery, irreversible electroporation (IRE), and salvage robot-assisted radical prostatectomy (sRARP). In his landmark 2022 study (51 citations), Dr. Geboers demonstrated the safety and feasibility of robot-assisted PSMA-radioguided surgery during primary robot-assisted radical prostatectomy, offering a novel method to improve intraoperative detection of lymph node metastases. He has also advanced the understanding of IRE as a focal therapy, showing in his IRE-IMMUNO study (2024, 13 citations) that it can downregulate immune suppression and induce systemic anti-tumour T-cell activation—a finding with profound implications for combining focal therapy with immunotherapy. Additionally, his work on salvage RARP following IRE (2022, 16 citations) provides critical feasibility and outcome data for managing recurrent prostate cancer after focal ablation. With a growing citation impact, Dr. Geboers is shaping the future of prostate cancer treatment by refining surgical precision and exploring the immune-modulating potential of minimally invasive therapies.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4